Breaking barriers to novel analgesic drug development

Nature Reviews Drug Discovery 16, 810 (2017).
doi:10.1038/nrd.2017.202

Author: Ajay S. Yekkirala, David P. Roberson, Bruce P. Bean & Clifford J. Woolf
Nature Reviews Drug Discovery16, 545–564 (2017)The compounds APD371,LY2828360, S-777469 and KHK6188 were incorrectly referred to as inhibitors of the cannabinoid receptors CB1 and CB2 in Table 1, when they are cannabinoid receptor agonists. In addition, KHK6188 is

Source: Nature Reviews Drug Discovery - October 6, 2017 Category: Drugs & Pharmacology Authors: Ajay S. Yekkirala David P. Roberson Bruce P. Bean Clifford J. Woolf Tags: Corrigendum Source Type: research